We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIR
RNS Number : 1965H
Circassia Pharmaceuticals Plc
05 June 2017
For immediate release
Circassia Pharmaceuticals plc
Persons Discharging Managerial Responsibilities and persons closely associated with them notification
Oxford, UK - 5 June 2017: Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) Persons Discharging Managerial Responsibilities and persons closely associated with them notification.
This form is for the use of persons discharging managerial responsibilities (PDMRs) as well as persons closely associated with them to notify transactions to the FCA under Article 19(1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ("The Market Abuse Regulation").
Once this form has been sent to the designated email address, it constitutes the "secure means of transmission" mandated in Article 2 of Regulation (EU) 2016/523. PDMRs as well as persons closely associated with them are required to use this form when submitting a notification under this article.
PDMR Notification Form Page
1 - Details of the person discharging managerial responsibilities/person closely associated
Name of natural person* Jean Jacques Garaud ------------------------ --------------------
2 - Reason for the notification
Position/status* Non-Executive Director (PDMR) -------------------------------- ----------------------- Initial notification/amendment* Initial Notification -------------------------------- ----------------------- In case of amendment, N/A please enter the previous notification reference number and explain the error that this notification needs amending -------------------------------- -----------------------
3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Full name of entity* Circassia Pharmaceuticals plc ------------------------ -------------------------- Legal Entity Identifier 2138006YAT138TOGA556 code ------------------------ -------------------------- In accordance with ISO 1744 LEI code ------------------------ --------------------------
4 - Details of the transaction(s)
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
Date Description Aggregated Aggregated Total Aggregated of Financial Price Volume Price Transaction ---------- -------------- ----------- ----------- ----------------- 02-Jun-17 Exercise GBP0.0008 77,500 GBP62.00 of options ---------- -------------- ----------- ----------- ----------------- 02-Jun-17 Sale of GBP0.8911 77,500 GBP69,060.25 shares ---------- -------------- ----------- ----------- ----------------- i. Exercise of options Description of the financial Circassia Holdings Ltd instrument, type of instrument* 2007 Unapproved Option Scheme --------------------------------- --------------------------------- Identification Code* GB00BJVD3B28 --------------------------------- --------------------------------- Nature of the transaction* Exercise of options --------------------------------- --------------------------------- Currency* GBP --------------------------------- --------------------------------- Price(s) and Volume (s) Price Volume Total ----------- ------- --------- GBP0.0008p 77,500 GBP62.00 ----------- ------- --------- --------------------------------- --------------------------------- Aggregated Information Price Volume Total ----------- ------- --------- GBP0.0008p 77500 GBP62.00 ----------- ------- --------- --------------------------------- --------------------------------- Date of Transaction* 2 June 2017 --------------------------------- --------------------------------- Place of Transaction* London: XLON --------------------------------- --------------------------------- ii. Sale of shares following exercise of options Description of the financial Circassia Holdings Ltd instrument, type of instrument* 2007 Unapproved Option Scheme --------------------------------- ------------------------------------- Identification Code* GB00BJVD3B28 --------------------------------- ------------------------------------- Nature of the transaction* Sale of shares --------------------------------- ------------------------------------- Currency* GBP --------------------------------- ------------------------------------- Price(s) and Volume (s) Price Volume Total ----------- ------- ------------- GBP0.8911p 77,500 GBP69,060.25 ----------- ------- ------------- --------------------------------- ------------------------------------- Aggregated Information Price Volume Total ----------- ------- ------------- GBP0.8911p 77,500 GBP69,060.25 ----------- ------- ------------- --------------------------------- ------------------------------------- Date of Transaction* 2 June 2017 --------------------------------- ------------------------------------- Place of Transaction* London: XLON --------------------------------- -------------------------------------
-Ends-
For further information, please contact: Circassia Pharmaceuticals plc Julien Cotta, Company Secretary +44 (0) 1865 405560
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBLGDLUXGBGRU
(END) Dow Jones Newswires
June 05, 2017 12:36 ET (16:36 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions